Back to search

Article

A single dose intranasal combination panebolavirus vaccine

2022-11-04

Abstract excerpt

<title>Abstract</title> <p>Ebolaviruses Ebola (EBOV), Sudan (SUDV) and Bundibugyo (BDBV) cause severe human disease, which may be accompanied by hemorrhagic syndrome, with high case fatality rates. Monovalent vaccines do not offer cross-protection against these viruses whose endemic areas overlap. Therefore, development of a panebolavirus vaccine is a priority. As a vaccine vector, human parainfluenza virus type...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
edfa7722-7712-5a8e-a739-c1eff5d5d995
DOI
10.21203/rs.3.rs-2211292/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A single dose intranasal combination panebolavirus vaccineDOI 10.21203/rs.3.rs-2211292/v1
Select a neighboring publication to make it the new centre.